NIH-funded research NIH-funded research

A new self-test for detecting HIV using a finger prick blood sample.

Official title: Nanopore-Based HIV Self-Test for Ultrasensitive p24 Quantification in FingerPrick Blood

Funded at University of Massachusetts Amherst · NIH-11236112 · Data updated 2026-11-12

This study is working on a new, easy-to-use home test for HIV that lets you take a tiny blood sample from your finger to check for the virus, helping people find out their status more accurately and privately, especially during early infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Amherst
NIH-funded
Lab location1 site (Hadley, United States)
Project startJanuary 18, 2023
Project endDecember 31, 2025
Funding year2025
Award (this year)$410,263
NIH project number7R61AI174295-03
Project IDNIH-11236112 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who are at risk of HIV infection or those who wish to know their HIV status, particularly in settings where traditional testing may not be readily available.

Less likely to help

Patients who are already diagnosed with HIV and are receiving treatment may not benefit directly from this research.

What this research studies

This research focuses on developing a nanopore-based self-test for HIV that allows individuals to collect a small blood sample from their finger and test it for the presence of HIV antigens. The goal is to improve the sensitivity of HIV testing, particularly for acute infections that current tests may miss. By enabling self-testing, the research aims to increase accessibility to HIV testing, allowing individuals to know their status in the privacy of their own homes. This approach could significantly enhance early detection and reduce the transmission of HIV.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and accessible HIV testing, helping to identify infections earlier and reduce transmission rates.

How similar studies have gone: While there have been advancements in HIV testing technologies, this specific nanopore-based approach for self-testing is relatively novel and has not been widely tested in the past.

Where this research is happening

  • University of Massachusetts Amherst
    Hadley, United States
    Active

Researchers

  • Principal investigator: Liu, Chang — University of Massachusetts Amherst
  • Study coordinator: Liu, Chang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.